glp-1 news today october 20 2025 weight loss drugs leave users low on key nutrients, study finds Alarming rise in weight loss

doi: 10.1507/endocrj.k09e-117

Recent clinical data shows GLP-1 receptor agonists improve insulin sensitivity and hormone balancetwo critical factors for fertility

Describe how these medications compare to other weight loss interventions and how previous clinical concepts are still applicable to patient populations struggling with overweight and obesity

Korean Food for GLP-1 Users: Healthy K-Food Guide Discover how to enjoy Korean cuisine while managing blood sugar on GLP-1 medications

Tirzepatide, a dual GIP/GLP-1 receptor agonist, represents the newest class of weight loss medications with remarkable clinical trial results from the SURMOUNT studies (Jastreboff et al., NEJM, 2022)

10.1371/journal.pone.0134676 165 OhC